
Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 20, 2021, titled "press release dated November 20, 2021 titled Zydus Cadila receives final approval from USFDA for Decitabine Injection .".
Filed with NSE ·

Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 20, 2021, titled "press release dated November 20, 2021 titled Zydus Cadila receives final approval from USFDA for Decitabine Injection .".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences